NSCLC Biomarkers: Expert Insights on New Targets, Testing Options, and Personalized Treatment

Review expert guidance for oncologists and pathologists on testing for new and emerging predictive biomarkers to guide treatment of NSCLC with this on-demand Webcast and slides from a live CCO Webinar.
Joel W. Neal, MD, PhD
Lauren L. Ritterhouse, MD

Downloadable Slidesets

Download these slides to review expert insights from a medical oncologist on established and emerging biomarkers critical to optimal use of targeted therapy and immunotherapy in patients with NSCLC.

Joel W. Neal, MD, PhD Released: October 13, 2020

Download these slides to review expert insights from a molecular pathologist on best practices for biomarker testing in the treatment of patients with advanced NSCLC.

Lauren L. Ritterhouse, MD Released: October 13, 2020

Download this short summary slideset of key takeaways from a live CCO Webinar featuring a medical oncologist and molecular pathologist discussing established and emerging biomarkers critical to optimal treatment of patients with advanced NSCLC.

Joel W. Neal, MD, PhD Lauren L. Ritterhouse, MD Released: October 21, 2020
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
Amgen
Merck Sharp & Dohme Corp.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue